Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential

Ellen Gorman, Jonathan Millar, Danny McAuley, Cecilia O'Kane

Research output: Contribution to journal › Article › peer-review

43 Citations (Scopus)
360 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis and COVID 19 infection: optimising the therapeutic potential'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science